HTG MOLECULAR DIAGNOSTICS, INC 4
4 · HTG MOLECULAR DIAGNOSTICS, INC · Filed Mar 14, 2016
Insider Transaction Report
Form 4
Gordon Debra A
V.P. and Chief Legal Counsel
Transactions
- Sale
Common Stock
2016-03-10$2.49/sh−1,211$3,016→ 23,518 total - Sale
Common Stock
2016-03-11$2.36/sh−4,215$9,928→ 19,303 total - Sale
Common Stock
2016-03-14$2.19/sh−109$238→ 19,194 total
Footnotes (4)
- [F1]Sale of shares of common stock under an existing Rule 10b5-1 Plan to cover tax withholding obligations incurred in connection with the issuance of shares of common stock to the Reporting Person on March 4, 2016 under the Issuer's annual incentive plan. The Issuer's annual incentive plan provides that performance-based bonuses may be paid in cash or shares of common stock, or a combination of both, at the discretion of the Issuer's board of directors.
- [F2]The weighted average sale price for the transaction reported was $2.4903, and the range of prices were between $2.35 and $2.69. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $2.3554, and the range of prices were between $2.1810 and $2.5900. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The weighted average sale price for the transaction reported was $2.1865, and the range of prices were between $2.1800 and $2.2000. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.